当前位置:首页 - 行情中心 - 九强生物(300406) - 财务分析

九强生物

(300406)

  

流通市值:55.71亿  总市值:77.25亿
流通股本:4.24亿   总股本:5.88亿

九强生物(300406)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润0.84亿元,每股收益0.14元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益421461.06万元,未分配利润287278.01万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产563145.76万元,负债141684.70万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入319,809,793.711,658,931,975.391,237,396,355.82821,722,324.81
营业总成本222,735,370.831,056,135,883.84793,399,425.93518,454,199.71
营业利润98,056,421.38624,050,562.29443,677,728.79302,644,933.66
利润总额98,024,052.97620,689,059.36441,532,898.97300,574,955.91
净利润83,572,615.29531,162,206372,402,279249,587,292.26
其他综合收益-35,824.27280,702.14-163,841.94110,421.36
综合收益总额83,536,791.02531,442,908.14372,238,437.06249,697,713.62
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计2,588,263,932.262,580,998,523.172,597,126,673.952,604,421,562.75
非流动资产合计3,043,193,655.962,993,966,639.182,860,040,238.912,694,255,324.26
资产总计5,631,457,588.225,574,965,162.355,457,166,912.865,298,676,887.01
流动负债合计244,861,231.38278,129,608.55287,588,481.79251,359,490.96
非流动负债合计1,171,985,800.331,164,035,605.411,205,030,145.961,197,546,091.23
负债合计1,416,847,031.711,442,165,213.961,492,618,627.751,448,905,582.19
归属于母公司股东权益合计4,219,983,288.434,138,374,136.023,970,743,202.73,855,551,704.93
股东权益合计4,214,610,556.514,132,799,948.393,964,548,285.113,849,771,304.82
负债和股东权益合计5,631,457,588.225,574,965,162.355,457,166,912.865,298,676,887.01
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计366,407,557.921,891,598,392.211,355,254,133.75897,787,083.25
经营活动现金流出小计295,460,843.411,277,586,462.95951,980,056.32675,320,318.53
经营活动产生的现金流量净额70,946,714.51614,011,929.26403,274,077.43222,466,764.72
投资活动现金流入小计88,602,966.24672,307,553.42274,149,272.89324,878,672.89
投资活动现金流出小计137,138,675.41690,927,208.69236,089,077.7183,127,236.47
投资活动产生的现金流量净额-48,535,709.17-18,619,655.2738,060,195.18241,751,436.42
筹资活动现金流入小计754,865.6129,258,866.2726,176,061.3622,823,499.65
筹资活动现金流出小计4,002,806.41205,739,197.57184,779,404.88157,541,550.91
筹资活动产生的现金流量净额-3,247,940.8-176,480,331.3-158,603,343.52-134,718,051.26
汇率变动对现金及现金等价物的影响-31,821.43515,978.68197,327.3528,579.05
现金及现金等价物净增加额19,131,243.11419,427,921.37282,928,256.44329,528,728.93
期末现金及现金等价物余额1,061,788,964.421,131,058,401.84994,558,736.911,041,159,209.4
最新报告期:2025-04-26
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
中泰证券于佳喜,祝嘉琦,谢木青0.941.091.292025-04-26
光大证券王明瑞,黎一江0.911.061.262025-04-02
中泰证券于佳喜,祝嘉琦,谢木青0.941.091.292025-03-31
TOP↑